Clinical Trial Update: Intralesional Cyclosporine for Alopecia Areata [EARLY_Phase 1]

View source ↗

Summary

A clinical trial is evaluating intralesional cyclosporine for alopecia areata in an early Phase 1 study. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: University of California, Davis | Conditions: Alopecia Areata | EARLY_Phase 1 | Status: RECRUITING